tiprankstipranks
Crispr Therapeutics management to meet with Piper Sandler
PremiumThe FlyCrispr Therapeutics management to meet with Piper Sandler
1M ago
Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics today
1M ago
Cathie Wood’s ARK Investment bought 409.5K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment bought 409.5K shares of Crispr Therapeutics today
1M ago
Crispr Therapeutics options imply 8.9% move in share price post-earnings
PremiumThe FlyCrispr Therapeutics options imply 8.9% move in share price post-earnings
1M ago
CRSP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CRSP Earnings this Week: How Will it Perform?
2M ago
Cathie Wood Trims Tesla Stake, Shifts Focus to This Lesser-Known Stock
Premium
Market News
Cathie Wood Trims Tesla Stake, Shifts Focus to This Lesser-Known Stock
2M ago
Pfizer withdrawal of Oxbryta raises questions, sends Fulcrum stock higher
PremiumThe FlyPfizer withdrawal of Oxbryta raises questions, sends Fulcrum stock higher
3M ago
Leerink sees little impact to genetic medicines from Pfizer’s Oxbryta withdrawal
Premium
The Fly
Leerink sees little impact to genetic medicines from Pfizer’s Oxbryta withdrawal
3M ago
Disc Medicine appoints Caffe as CRO
Premium
The Fly
Disc Medicine appoints Caffe as CRO
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100